BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Merz Pharma Group 

Eckenheimer Landstraße 100

Frankfurt am Main    D-60318  Germany
Phone: 49-69-1503-0 Fax: 49-69-1503-200


SEARCH JOBS


Industry
Pharmaceutical






 Company News
Merz Pharma Group North America Announces Internal Promotions within its North American Leadership Team 9/30/2013 10:29:17 AM    More...
Merz Pharma Group Acquires Swiss Dermatology Company Neocutis S.A. 7/31/2013 10:02:44 AM    More...
Merz Pharma Group Declines to Raise Bid for Obagi Medical Products, Inc. (OMPI), Yielding to Valeant Pharmaceuticals International (VRX) 4/8/2013 7:53:27 AM    More...
Merz Pharma Group Offers $383.5 Million for Obagi Medical Products, Inc. (OMPI), Tops Deal Announced Last Month With Valeant Pharmaceuticals International (VRX) 4/2/2013 7:32:19 AM    More...
Merz Pharma Group Announces Promotion of Hyunna Coelho to Vice President, Commercial Excellence 10/1/2012 11:22:33 AM    More...
Merz Pharma Group Announces the Acquisition of CUVPOSA® (glycopyrrolate) Oral Solution, First and Only FDA-Approved Treatment for Pediatric Chronic Severe Drooling Associated With Neurologic Conditions 8/27/2012 10:52:14 AM    More...
The Merz Pharma Group Appoints William D. Humphries as New North American Chief Executive Officer 3/14/2012 7:39:19 AM    More...
Merz Pharma Group to Complete Acquisition of BioForm Medical, Inc. 2/19/2010 9:54:05 AM    More...
Merz Pharma Group Successfully Completes BioForm Medical, Inc. Tender Offer with over 94 Percent of Shares Tendered 2/16/2010 10:11:24 AM    More...
Merz Pharma Group Obtains HSR Clearance in Connection with BioForm Medical, Inc. Tender Offer 2/3/2010 10:21:14 AM    More...
12

//-->